Malignant architectural distortion ably diagnosed on breast imaging by human-AI combo

Combining ensemble artificial intelligence (AI) models with reads from breast radiologists of mixed experience levels can help health systems consistently diagnose malignant architectural distortion on mammography.

Academic researchers at China’s Guangzhou University, along with industry researchers in the U.S. and China, found as much when they conducted a retrospective review of mammograms acquired and interpreted over a six-year period at the university’s affiliated medical center.

The study is current in Frontiers in Oncology.[1]

In introducing their findings, Daniel Q. Chen, Bo Liu and colleagues name breast architectural distortion as “the most difficult type of tumor to detect and the most commonly missed abnormality due to its inherent subtlety and varying attributes.”

The study’s imaging dataset included 177 malignant and 90 benign architectural distortion findings, all of which were confirmed by pathology results in patients’ electronic medical records.

Comparing the performances of unaided radiologists with AI-aided peers at finding the malignancies, and of AI ensembles alone, the team recorded several telling results.

For example, in one round, combining AI with a junior radiologist brought a specificity of 72.7% and sensitivity of 91.7%. These scores represented significant improvements over AI alone and radiologist alone.

The cumulative results of these and other rounds of comparison “underscore the potential of using deep learning methods to enhance the overall accuracy of pretest mammography for malignant architectural distortion,” the authors comment in their discussion.

They further note the “large gap” in the diagnostic acumen of radiologists across the many regions of China, suggesting the implications of the study extend beyond architectural distortion patients:

Radiologists [in China] are required to report on X-ray, CT and MR examination results, and even imaging technicians are required for this work some of the time. Our results suggest that adding AI to clinical mammography interpretation in settings with junior radiologists could yield significant performance improvements, with the potential to reduce health care system expenditures, address the recurring shortage of experienced radiologists, and reduce missed detection of early breast cancer.”

The study is available in full for free

More Coverage of Mammogram Architectural Distortion:

When does worrisome architectural distortion signal malignancy on mammography?

DBT detects more architectural distortion lesions than 2D mammography alone

New research can help radiologists manage architectural distortion identified via DBT exams

3D mammography detects more architectural distortions than 2D

Tomosynthesis trumps mammo alone for spotting architectural distortion

Find more breast imaging news 

Find more AI in radiology news

 

 

Reference:

1. Yun Wan, Yunfei Tong, Yuanyuan Liu, Yan Huang, Guoyan Yao, Daniel Q. Chen and Bo Liu, “Evaluation of the Combination of Artificial Intelligence and Radiologist Assessments to Interpret Malignant Architectural Distortion on Mammography.” Frontiers in Oncology, April 20, 2022. DOI: https://doi.org/10.3389/fonc.2022.880150.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.